SEC Comment Letter 0000000000-23-009357 to Gossamer Bio, Inc. (GOSS) (CIK 0001728117) (GOSS)
Gossamer Bio, Inc. (GOSS) (CIK 0001728117)
Date: Aug. 24, 2023 · CIK: 0001728117 · Accession: 0000000000-23-009357
AI Filing Summary & Sentiment
File numbers found in text: 333-274056
Letter
United States securities and exchange commission logo August 24, 2023 Jeff Boerneke General Counsel Gossamer Bio, Inc. 3013 Science Park Road San Diego, CA 92121 Re:Gossamer Bio, Inc. Registation Statement on Form S-3 Filed August 18, 2023 File No. 333-274056 Dear Jeff Boerneke: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kevin Reyes
Show Raw Text
United States securities and exchange commission logo
August 24, 2023
Jeff Boerneke
General Counsel
Gossamer Bio, Inc.
3013 Science Park Road
San Diego, CA 92121
Re:Gossamer Bio, Inc.
Registation Statement on Form S-3
Filed August 18, 2023
File No. 333-274056
Dear Jeff Boerneke:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Kevin Reyes